Thienopyrimidines as phosphodiesterase inhibitors

US6787548B1 · kind B1 · utility

Assignee

• MERCK PATENT GESELLSCHAFT MIT BESHRANK TER HAFTUNG · DE

Inventors

• Rochus Jonas · Darmstadt, DE
• Pierre Schelling · Mühltal, DE
• Franz-Werner Kluxen · Darmstadt, DE
• Maria Christadler · Darmstadt, DE

Key dates

• Filing date: May 10, 2002
• Grant date: Sep 7, 2004
• Expiry date: Aug 27, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Thienopyrimidines of the formula I and their physiologically acceptable salts,in whichR1, R2 and X have the meanings indicated in claim 1, exhibit phosphodiesterase V inhibition and can be employed for the treatment of disorders of the cardiovascular system and for the treatment and/or therapy of potency disorders.